Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by BRMS1L shows sequence similarity to the human breast carcinoma metastasis suppressor (BRMS1) protein and the mammalian Sds3 (suppressor of defective silencing 3) proteins. Additionally we are shipping BRMS1L Antibodies (48) and and many more products for this protein.
Showing 7 out of 7 products:
low levels of BRMS1L is associated with glioma progression and plays as an independent poor prognosis biomarker. The up-regulation of BRMS1L suppresses glioma cells' invasion. All of those indicate that BRMS1L is a novel prognostic biomarker with potential anti-invasion therapeutic implications in GBM.
findings indicate the expression of Brms1L depends on beta-catenin activity and contributes to follicle stimulating hormone beta induction by Gonadotropin-Releasing Hormone.
The protein encoded by this gene shows sequence similarity to the human breast carcinoma metastasis suppressor (BRMS1) protein and the mammalian Sds3 (suppressor of defective silencing 3) proteins. This protein is a component of the mSin3a family of histone deacetylase complexes (HDAC).
BRMS1-homolog protein p40
, BRMS1-like protein p40
, breast cancer metastasis-suppressor 1-like protein
, breast cancer metastasis-suppressor 1-like
, breast cancer metastasis-suppressor 1-like protein-A